Search

Vipin Suri

from Belmont, MA
Age ~51
Get Report
Related to:
Wei M ZhaoHuiqun ZhaoZequan ZhaoPeiling Zhao, 69Stephen H Chung, 59
Connected to:
Abhishek Suri, 41Akshay Suri, 31Alberto Suri, 70Ana Suri, 53Anil Suri, 56Anish Suri, 57Arshad Suri, 75Avinash Suri, 84Dustin E Suri, 45Estrella Suri, 37

Vipin Suri Phones & Addresses

  • 3 Coolidge Rd, Belmont, MA 02478
  • 22 Stearns St, Waltham, MA 02453 (781) 209-2281
  • 22 Stearns St APT 1, Waltham, MA 02453 (781) 209-2281
  • 25 Brown St, Waltham, MA 02453
  • 62 Bedford St, Waltham, MA 02453 (781) 891-7568
  • 59 South St, Waltham, MA 02453 (781) 891-7568

Work

Company: Glaxosmithkline, sirtris dpu May 2011 Address: Cambridge, MA Position: Director (pharmacology)

Education

Degree: Doctor of Philosophy (PhD) School / High School: Brandeis University 1995 to 2000 Specialities: Biochemistry

Skills

Drug Discovery • Biotechnology • Pharmacology • Pharmaceutical Industry • Drug Development • Lifesciences • Life Sciences • Biochemistry • Clinical Development • Molecular Biology • Cell Biology • Oncology • Technology Transfer • Biopharmaceuticals • Cell • Immunology • Cell Culture • Chromatography • Cro • Lead Change • Regulatory Affairs • Clinical Trials • In Vivo • Organic Chemistry • Fda • Medicinal Chemistry • Validation • Biomarkers • Vaccines • Protein Chemistry • Glp • Infectious Diseases • Neuroscience • R&D • Pharmacokinetics • Cancer • Hplc

Industries

Pharmaceuticals

Resumes

Resumes

Vipin Suri Photo 1

Chief Scientific Officer

View page
Location:
400 Technology Sq, Cambridge, MA 02139
Industry:
Pharmaceuticals
Work:
GlaxoSmithKline, Sirtris DPU - Cambridge, MA since May 2011
Director (Pharmacology)
GlaxoSmithKline, Sirtris DPU - Cambridge, MA Apr 2010 - May 2011
Associate Director (Pharmacology)
Wyeth - Cambridge, MA Sep 2000 - Mar 2010
Principal Research Scientist II
Education:
Brandeis University 1995 - 2000
Doctor of Philosophy (PhD), Biochemistry Yale University - Yale School of Management 2006 - 2008
Skills:
Drug Discovery
Biotechnology
Pharmacology
Pharmaceutical Industry
Drug Development
Lifesciences
Life Sciences
Biochemistry
Clinical Development
Molecular Biology
Cell Biology
Oncology
Technology Transfer
Biopharmaceuticals
Cell
Immunology
Cell Culture
Chromatography
Cro
Lead Change
Regulatory Affairs
Clinical Trials
In Vivo
Organic Chemistry
Fda
Medicinal Chemistry
Validation
Biomarkers
Vaccines
Protein Chemistry
Glp
Infectious Diseases
Neuroscience
R&D
Pharmacokinetics
Cancer
Hplc

Business Records

Name / Title
Company / Classification
Phones & Addresses
Vipin Suri
Director
NIDARES, INC
130 Robert Rd, Marlborough, MA 01752
22 Steams St UNIT 1, Waltham, MA 02453

Publications

Us Patents

11-Beta Hsd1 Inhibitors

View page
US Patent:
20060025445, Feb 2, 2006
Filed:
Aug 2, 2005
Appl. No.:
11/196643
Inventors:
Jason Xiang - Winchester MA, US
John McKew - Arlington MA, US
Steve Tam - Wellesley MA, US
Manus Ipek - Watetown MA, US
Vipin Suri - Waltham MA, US
Tarek Mansour - New City NY, US
International Classification:
A61K 31/445
A61K 31/40
A61K 31/381
US Classification:
514317000, 514471000, 514408000, 514602000, 546229000, 548561000, 549491000, 564086000, 549076000
Abstract:
This invention relates to inhibiting 11-beta HSD1.

11-Beta Hsd 1 Inhibitors

View page
US Patent:
20070219198, Sep 20, 2007
Filed:
Feb 7, 2007
Appl. No.:
11/703522
Inventors:
Jason Xiang - Winchester MA, US
Eddine Saiah - Brookline MA, US
Steve Tam - Wellesley MA, US
John Mckew - Arlington MA, US
Lihren Chen - Bedford MA, US
Manus Ipek - Watertown MA, US
Katherine Lee - West Newton MA, US
Jianchang Li - Carlisle MA, US
Wei Li - Acton MA, US
Tarek Mansour - New City NY, US
Vipin Suri - Waltham MA, US
Richard Vargas - Lexington MA, US
Yuchuan Wu - Acton MA, US
Jinbo Lee - Andover MA, US
Eva Binnun - Boston MA, US
Douglas Wilson - Ayer MA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/5377
A61K 31/497
A61K 31/496
C07D 413/02
C07D 403/02
C07D 409/02
US Classification:
514235500, 514252130, 514252110, 514253010, 514254010, 544121000, 544357000, 544360000, 544379000, 514151000
Abstract:
This invention relates to inhibiting 11βHSD1.

11-Beta Hsd1 Inhibitors

View page
US Patent:
20100029648, Feb 4, 2010
Filed:
Aug 11, 2009
Appl. No.:
12/539232
Inventors:
Jason Shaoyun Xiang - Winchester MA, US
Eddine Saiah - Brookline MA, US
Steve Y. Tam - Wellesley MA, US
John C. McKew - Arlington MA, US
Lihren Chen - Bedford MA, US
Manus Ipek - Watertown MA, US
Katherine Lee - West Newton MA, US
Jianchang Li - Carlisle MA, US
Wei Li - Acton MA, US
Tarek Suhayl Mansour - New City NY, US
Vipin Suri - Waltham MA, US
Richard Vargas - Lexington MA, US
Yuchuan Wu - Acton MA, US
Jinbo Lee - Andover MA, US
Eva Binnun - Boston MA, US
Douglas P. Wilson - Ayer MA, US
International Classification:
A61K 31/5377
A61K 31/497
A61K 31/4965
A61K 31/4545
US Classification:
5142358, 51425301, 51425502, 514318
Abstract:
This invention relates to inhibiting 11βHSD1.

Compositions And Methods For Dhfr Tunable Protein Regulation

View page
US Patent:
20220348937, Nov 3, 2022
Filed:
Sep 4, 2020
Appl. No.:
17/753505
Inventors:
- Cambridge MA, US
Janine Elizabeth Elya - Cambridge MA, US
Grace Y. Olinger - Swampscott MA, US
Vipin Suri - Belmont MA, US
International Classification:
C12N 15/63
A61K 35/17
C12N 9/06
A61K 47/00
Abstract:
The present disclosure is related to compositions and methods for the regulated and controlled expression of proteins.

Ca2-Il15 Fusion Proteins For Tunable Regulation

View page
US Patent:
20220332780, Oct 20, 2022
Filed:
Sep 10, 2020
Appl. No.:
17/753594
Inventors:
- Cambridge MA, US
Dhruv Kam SETHI - Cambridge MA, US
Meghan C. LANGLEY - Cambridge MA, US
Tucker Read EZELL - Cambridge MA, US
Dexue SUN - Cambridge MA, US
Jennifer Leah GORI - Jamaica Plain MA, US
Geetha Hanna MYLVAGANAM - Boston MA, US
Michelle OLS - Northborough MA, US
Michelle FLEURY - Cambridge MA, US
Celeste RICHARDSON - Brookline MA, US
James A. STORER - Medford MA, US
Vipin SURI - Belmont MA, US
Shyamsundar SUBRAMANIAN - Downingtown PA, US
Colleen FOLEY - Cambridge MA, US
Molly Reed PERKINS - Milton MA, US
Jeremy Hatem TCHAICHA - Belmont MA, US
Scott Francis HELLER - Stoughton MA, US
International Classification:
C07K 14/54
C07K 14/725
A61K 31/427
A61K 35/17
A61P 35/00
C12N 15/62
C12N 5/0783
C12N 15/86
C12N 9/88
Abstract:
The present disclosure provides drug responsive domains derived from human carbonic anhydrase 2 that can modulate protein stability for human interleukin 15 (EL15) payloads, as well as compositions and methods of use thereof.

Ca2 Compositions And Methods For Tunable Regulation

View page
US Patent:
20220267398, Aug 25, 2022
Filed:
Jun 12, 2020
Appl. No.:
17/596277
Inventors:
- Cambridge MA, US
Vipin SURI - Belmont MA, US
Dexue SUN - Cambridge MA, US
Dhruv Kam SETHI - Westwood MA, US
Michael SCHEBESTA - Cambridge MA, US
Michelle Lois FLEURY - Cambridge MA, US
Kutlu Goksu ELPEK - Arlington MA, US
International Classification:
C07K 14/54
C07K 14/725
C07K 14/705
C12N 9/88
Abstract:
The present disclosure provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities.

Cd40L Compositions And Methods For Tunable Regulation

View page
US Patent:
20220175781, Jun 9, 2022
Filed:
Mar 6, 2020
Appl. No.:
17/436997
Inventors:
- Cambridge MA, US
Michelle Lois FLEURY - Cambridge MA, US
Kutlu Goksu ELPEK - Cambridge MA, US
Elizabeth Jane WEISMAN - Jamaica Plain MA, US
Vipin SURI - Belmont MA, US
Dexue SUN - Cambridge MA, US
Dan Jun LI - Cambridge MA, US
Steven Mark SHAMAH - Acton MA, US
Michael Joseph BRISKIN - Lexington MA, US
Celeste RICHARDSON - Brookline MA, US
Tariq A. KASSUM - Boston MA, US
Michelle Lynn OLS - Northborough MA, US
Brian DOLINSKI - Cambridge MA, US
Mara Christine INNISS - Beverly MA, US
Emily BRIDEAU - Cambridge MA, US
Jennifer Leah GORI - Jamaica Plain MA, US
Dhruv Kam SETHI - Westwood MA, US
Assignee:
Obsidian Therapeutics, Inc. - Cambridge MA
International Classification:
A61K 31/519
C12N 9/06
A61K 31/55
Abstract:
The present disclosure provides regulatable biocircuit systems, effector modules and compositions for cancer immunotherapy. Methods for inducing anti-cancer immune responses in a subject are also provided.

Ca2 Compositions And Methods For Tunable Regulation

View page
US Patent:
20210069248, Mar 11, 2021
Filed:
Sep 10, 2020
Appl. No.:
17/017670
Inventors:
- Cambridge MA, US
Meghan C. LANGLEY - Stoughton MA, US
Tucker Read EZELL - Acton MA, US
Dexue SUN - Cambridge MA, US
Jennifer Leah GORI - Jamaica Plain MA, US
Geetha Hanna MYLVAGANAM - Boston MA, US
Michelle OLS - Northborough MA, US
Michelle FLEURY - Cambridge MA, US
Celeste RICHARDSON - Brookline MA, US
James A. STORER - Medford MA, US
Vipin SURI - Belmont MA, US
Shyamsundar SUBRAMANIAN - Downington PA, US
Colleen FOLEY - Cambridge MA, US
Molly Reed PERKINS - Milton MA, US
Jeremy Hatem TCHAICHA - Belmont MA, US
Scott Francis HELLER - Stoughton MA, US
Assignee:
Obsidian Therapeutics, Inc. - Cambridge MA
International Classification:
A61K 35/17
C12N 15/86
C07K 14/54
C12N 9/88
A61K 31/433
Abstract:
The present disclosure provides drug responsive domains derived from human carbonic anhydrase 2 that can modulate protein stability for human interleukin 15 (IL15) payloads, as well as compositions and methods of use thereof.
Control profile
Vipin Suri from Belmont, MA, age ~51 Get Report